Filter

131-140 of 374 results

  • Distributing a COVID-19 Vaccine Across the U.S. – A Look at Key Issues

    Issue Brief

    This brief examines key policy challenges and issues related to distributing a COVID-19 vaccine in the U.S., including funding, supply and logistics, federal, state, and local authorities, insurance coverage, addressing racial and ethnic disparities, and communication and trust.

  • How are States Prioritizing Who Will Get the COVID-19 Vaccine First?

    News Release

    The first Americans were vaccinated today as COVID-19 vaccines are being distributed across the country. A new KFF review of states’ releases and statements about their vaccination priorities finds that most states are following the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices recommendations for the highest priority group (health care workers and long-term care residents), with some choosing to start with one of the populations in the first weeks as…

  • A Look at How Medicaid Agencies Are Assisting with the COVID-19 Vaccine Roll-Out

    Issue Brief

    As of February 2021, there are three COVID-19 vaccines approved for emergency use in the U.S. and states are playing a central role in their timely distribution and prioritizing eligible populations. Because Medicaid covers for over 77 million enrollees, including groups disproportionately at risk of contracting COVID-19 as well as hard-to-reach groups, Medicaid agencies can be important partners for the public health agencies that are typically leading the state COVID-19 vaccination efforts. This brief provides…

  • Supply vs Demand: Which States are Reaching their COVID-19 Vaccine Tipping Points?

    Policy Watch

    This analysis examines overall COVID-19 vaccination levels and how the rate of vaccinations over the last week has changed at state-level and national level. There is significant variability by state in how many adults in the US have been vaccinated with at least one dose. Most states are also seeing a decline in the pace of vaccinations, indicating that they may be approaching the point when vaccine supply exceeds demand.

  • New Campaign from THE CONVERSATION / LA CONVERSACIÓN Responds to Information Needs about COVID-19 Vaccines Among Latinos and Spanish-speaking People in U.S.

    News Release

    News Release May 20, 2021 – THE CONVERSATION / LA CONVERSACIÓN expands to address information needs about the COVID-19 vaccines in the Latinx community with new videos featuring doctors, nurses and promotoras (community health workers) in English and Spanish. This installment of the campaign is produced by KFF (Kaiser Family Foundation) under its Greater Than COVID public information response and presented with UnidosUS. “THE CONVERSATION / LA CONVERSACIÓN campaign—and our efforts with the UnidosUS Esperanza Hope for…

  • COVID-19 Vaccine Breakthrough Cases: Data from the States

    Policy Watch

    We reviewed the websites and other official state sources for all 50 states and D.C. to see which are providing data on COVID-19 breakthrough cases, hospitalizations and deaths, how regularly, and what those data may tell us.

  • The Last Major Phase of the COVID-19 Vaccination Roll-out: Children Under 5

    Issue Brief

    With the FDA authorization of both Moderna and Pfizer’s COVID-19 vaccine for children between the ages of 6 months and 5, the last major phase of the U.S. vaccination roll-out is underway. This brief provides an overview of the characteristics of children under the age of 5 and discusses some issues to consider in rolling out vaccination to this age group.